Platform
GrowthCurve Capital takes majority stake in TailorMed
TailorMed, which runs a network-powered medication success platform, receives a majority investment from GrowthCurve Capital.
TailorMed announced a majority investment from GrowthCurve Capital. The company said the investment will support its continued growth and accelerate innovation at its network-powered medication success platform.
According to the announcement, the platform is intended to help more patients access, afford and stay on therapy.
Deal facts
- Target
- TailorMed
- Business
- Network-powered medication success platform helping patients access, afford and stay on therapy
- Buyer
- GrowthCurve Capital
- Sponsor
- GrowthCurve Capital
- Deal type
- Platform
- Status
- Completed
- Announced
- Monday, November 2, 2026
Sources
- accessnewswire.comNov 2, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.